A phase 2 trial of durvalumab with first line chemotherapy in mesothelioma with a safety run in.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Cisplatin (Primary) ; Durvalumab (Primary) ; Pemetrexed (Primary)
- Indications Mesothelioma
- Focus Therapeutic Use
- Acronyms DREAM
- 01 Dec 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jan 2017 Status changed from not yet recruiting to recruiting.
- 08 Sep 2016 New trial record